About Spectra Analysis
Spectra Analysis is a company based in Boston (United States) founded in 2004 by Bill Carson was acquired by DANI Instruments in January 2015. Spectra Analysis has raised $9.25 million across 7 funding rounds from investors including DANI Instruments. Spectra Analysis offers products and services including DiscovIR10, DiscovIR-GC, and DiscovIR-LC. Spectra Analysis operates in a competitive market with competitors including Impedimed, Rigaku, Speclipse, Anvajo and Ahura Scientific, among others.
- Headquarter Boston, United States
- Founders Bill Carson
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spectra Analysis Instruments, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.25 M (USD)
in 7 rounds
-
Latest Funding Round
$1.35 M (USD), Series A
Mar 27, 2013
- Investors
-
Employee Count
Not available
-
Acquired by
DANI Instruments
(Jan 09, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spectra Analysis
Spectra Analysis offers a comprehensive portfolio of products and services, including DiscovIR10, DiscovIR-GC, and DiscovIR-LC.
Software for infrared spectroscopy analysis of compounds.
Detector for gas chromatography in molecular analysis.
FTIR detector for liquid chromatography applications.
Funding Insights of Spectra Analysis
Spectra Analysis has successfully raised a total of $9.25M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $1.35 million completed in March 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Spectra Analysis
Spectra Analysis has secured backing from 1 investor. Prominent investors backing the company include DANI Instruments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Gas chromatography and analytical instruments are manufactured by DANI Instruments.
|
Locked | Locked | Locked |
Investor details for Spectra Analysis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spectra Analysis
Investment portfolio details for Spectra Analysis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spectra Analysis
Detailed financials for Spectra Analysis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spectra Analysis Comparisons
Peer comparison for Spectra Analysis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spectra Analysis
Spectra Analysis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Impedimed, Rigaku, Speclipse, Anvajo and Ahura Scientific, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technologies for non-invasive fluid status assessment and monitoring are developed.
|
|
| Locked | Locked | Locked |
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
|
|
| Locked | Locked | Locked |
Molecular spectroscopy systems for early skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Point-of-care solutions for laboratory diagnostics are provided by Anvajo.
|
|
| Locked | Locked | Locked |
Optical systems are developed for identifying solid and liquid chemicals.
|
Detailed competitors of Spectra Analysis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spectra Analysis
Complete news archive for Spectra Analysis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spectra Analysis
Spectra Analysis was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Spectra Analysis is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
George Giansanti is the current CEO of Spectra Analysis.
Spectra Analysis is a funded company, having raised a total of $9.25M across 7 funding rounds to date.
Spectra Analysis was founded in 2004 in Boston, United States, as a provider of infrared spectroscopic instruments. Systems for molecular analysis are designed and developed by the company, targeting analytical applications in sectors such as forensics, polymer science, drug formulation, and agriculture for flavor and fragrance characterization. Organic and inorganic compounds are identified and structurally characterized using infrared spectroscopy methods.
Spectra Analysis's top competitors include Impedimed, Linear Diagnostics and Anvajo.
Spectra Analysis offers DiscovIR10, DiscovIR-GC, and DiscovIR-LC.
Spectra Analysis has 1 investor. Key investors include DANI Instruments.